Search | Médecins Sans Frontières Access Campaign

3 results found

MSF protests at Wall Street after J&J announces 2019 sales increase

Press release |

22 January 2020

As J&J release earnings, MSF protests price of lifesaving TB drug

MSF protested in front of the New York Stock Exchange in New York today, demanding the pharmaceutical corporation Johnson & Johnson make the tuberculosis drug bedaquiline available for all people with drug-resistant TB or no more than ...

Tags Tuberculosis drug-resistant TBtuberculosis bedaquiline access to medicines Johnson & Johnson

Issue brief |

18 September 2019

Making the Switch

Saving more lives with optimal treatment for drug-resistant TB

Tags Tuberculosis drug-resistant TBtuberculosis moxifloxacinlinezolidbedaquilinedelamanid access to medicinesdiagnostic testsgeneric medicinesinnovationresearch and development (R&D)voluntary licence Union Conference on Lung HealthTB AllianceJohnson & JohnsonOtsuka DRTB Drugs Under the Microscope

Issue brief |

22 October 2018

DR-TB Drugs Under the Microscope, 5th Edition

The 5th edition of “DR-TB Drugs Under the Microscope” chronicles the changing landscape of available treatments for DR-TB, outlines the key barriers to accessing the most effective treatments, and makes recommendations for action that ...

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

As J&J release earnings, MSF protests price of lifesaving TB drug

Making the Switch

DR-TB Drugs Under the Microscope, 5th Edition